Effexor online research references









  • Newer antidepressants: a comparison of tolerability in general practice.
  • Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.
  • Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat.
  • The decreased in vivo clearance of CYP2D6 substrates by CYP2D6*10 might be caused not only by the low-expression but also by low affinity of CYP2D6.
  • Do antidepressants affect motivation in conditioned place preference?
  • Use of vancomycin silica stationary phase in packed capillary electrochromatography I. Enantiomer separation of basic compounds.
  • Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction.
  • Presynaptic Ca2+/calmodulin-dependent protein kinase II: autophosphorylation and activity increase in the hippocampus after long-term blockade of serotonin reuptake.
  • Attenuation of morphine dependence and withdrawal in rats by venlafaxine, a serotonin and noradrenaline reuptake inhibitor.
  • A high-performance liquid chromatographic method for the simultaneous determination of venlafaxine and O-desmethylvenlafaxine in biological fluids.
  • Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function.
  • Depressive disorders and antidepressive therapy. A comparison of neurology practice and psychiatric clinic
  • Rapid high-performance liquid chromatographic measurement of venlafaxine and O-desmethylvenlafaxine in human plasma. Application to management of acute intoxications.
  • On-line capillary electrophoresis-electrospray mass spectrometry for the stereoselective analysis of drugs and metabolites.
  • Noradrenergic antidepressants: does chronic treatment increase or decrease nuclear CREB-P?
  • Sertralilne, paroxetine and venlafaxine in refugee post traumatic stress disorder with depression symptoms.
  • Effects of chronically administered venlafaxine on 5-HT receptor activity in rat hippocampus and hypothalamus.
  • The effects of a selective noradrenaline reuptake inhibitor on the urethra: an in vitro and in vivo study.
  • Venlafaxine and mirtazapine: different mechanisms of antidepressant action, common opioid-mediated antinociceptive effects--a possible opioid involvement in severe depression?
  • Rx drugs
  • Venlafaxine versus stimulant therapy in patients with dual diagnosis ADD and depression.
  • Evaluating the tolerability of the newer antidepressants.
  • Once daily sustained release tablets of venlafaxine, a novel antidepressant.
  • Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats.
  • Healthcare expenditure in patients treated with venlafaxine or selective serotonin reuptake inhibitors for depression and anxiety.
  • Comparing speeds of effectiveness of two treatments.
  • Venlafaxine hydrochloride (Effexor) relieves thermal hyperalgesia in rats with an experimental mononeuropathy.
  • Changes in regional cerebral blood flow with venlafaxine in the treatment of major depression.
  • Application of a first-pass effect model to characterize the pharmacokinetic disposition of venlafaxine after oral administration to human subjects.
  • The antihyperalgesic effect of venlafaxine in diabetic rats does not involve the opioid system.
  • Rx drugs
  • Evidence for an antihyperalgesic effect of venlafaxine in vincristine-induced neuropathy in rat.
  • Pharmacological effects of venlafaxine, a new antidepressant, given repeatedly, on the alpha 1-adrenergic, dopamine and serotonin systems.
  • Effects of venlafaxine on extracellular 5-HT, dopamine and noradrenaline in the hippocampus and on peripheral hormone concentrations in the rat in vivo.
  • Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats.
  • Pharma-Clinics. The drug of the month. Venlafaxine (Efexor)
  • Use of bupropion with SRIs and venlafaxine.
  • Lack of beta adrenoceptor desensitization in brain following the dual noradrenaline and serotonin reuptake inhibitor venlafaxine.
  • Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramine.
  • Venlafaxine-tramadol similarities.
  • Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative.
  • Venlafaxine for treatment-resistant unipolar depression.
  • Pharmacokinetics of venlafaxine and O-desmethylvenlafaxine in laboratory animals.
  • Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites.
  • Venlafaxine oxidation in vitro is catalysed by CYP2D6.
  • DMI, Wy-45,030, Wy-45,881 and ciramadol inhibit locus coeruleus neuronal activity.
  • Electrochemical behaviour of Venlafaxine and its determination in pharmaceutical products using square wave voltammetry.
  • Effect of venlafaxine hydrochloride in different preparations of isolated guinea-pig and rat organ tissues.
  • Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat.
  • Metabolic disposition of 14C-venlafaxine in mouse, rat, dog, rhesus monkey and man.
  • Effect of subchronic antidepressant treatments on behavioral, neurochemical, and endocrine changes in the forced-swim test.







    online pharmacies || Hair Million herbal formula for hair loss and hair growth || Tramadol online || Tramadol || Antibiotics || Antibiotics and prescription medications online literature || Antibiotics